Position history for BlackRock, Inc.'s holdings in PROTAGONIST THERAPEUTICS INC
BlackRock, Inc. holds 9.8M shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $1B as of 2026-Q1. The position was increased (+0.7% shares). PTGX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$1B
Current Shares
9.8M
Total Value Change
+$649.2M
Total Shares Change
-105,248
Other major holders of PTGX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, CAPITAL FUND MANAGEMENT S.A.
Increased |
| 9.8M |
+0.7% |
| $1B |
| 0.0% |
| $91.30 |
32 |
| 2025-Q4 | Increased | 9.7M | +3.3% | $848.6M | 0.0% | $87.26 | 33 |
| 2025-Q3 | Decreased | 9.4M | -2.4% | $624.7M | 0.0% | $65.14 | 0 |
| 2025-Q2 | Decreased | 9.6M | -1.1% | $532.3M | 0.0% | $55.69 | 0 |
| 2025-Q1 | Decreased | 9.7M | -1.5% | $470.9M | 0.0% | $48.88 | 0 |
| 2024-Q4 | New | 9.9M | - | $381.5M | 0.0% | $38.51 | 43 |